{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:12:09Z","timestamp":1789517529223,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Teikoku Seiyaku"},{"DOI":"10.13039\/100009954","name":"Taiho Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitsubishi Tanabe Pharma"},{"name":"Torii Pharmaceutical"},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kyorin Pharmaceutical"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.alit.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T18:58:33Z","timestamp":1541012313000},"page":"207-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"68","author":[{"given":"Kimihiro","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1081-1206(10)63532-6","article-title":"Epidemiology of Japanese cedar pollinosis throughout Japan","volume":"91","author":"Okuda","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.alit.2016.11.001","article-title":"Japanese guidelines for allergic rhinitis 2017","volume":"66","author":"Okubo","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2018.08.011_bib3","series-title":"[Practical Guideline for the Management of Allergic Rhinitis in Japan 2013]","author":"PG-MARJ Committee","year":"2013"},{"key":"10.1016\/j.alit.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2332\/allergolint.14-RAI-0768","article-title":"Japanese guideline for allergic rhinitis 2014","volume":"63","author":"Okubo","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2012.06.026","article-title":"Sleep and allergic disease: a summary of the literature and future directions for research","volume":"130","author":"Koinis-Mitchell","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","article-title":"Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update","volume":"119","author":"Dykewicz","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Indian J Dermatol"},{"issue":"Suppl 100","key":"10.1016\/j.alit.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/all.12531","article-title":"Update on rupatadine in the management of allergic disorders","volume":"70","author":"Mullol","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03168446","article-title":"Role of histamine and platelet-activating factor in allergic rhinitis","volume":"60","author":"Alfaro","year":"2004","journal-title":"J\u00a0Physiol Biochem"},{"key":"10.1016\/j.alit.2018.08.011_bib10","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.2500\/ajra.2013.27.3856","article-title":"Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients","volume":"27","author":"Mu\u00f1oz-Cano","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.alit.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"e0163020","DOI":"10.1371\/journal.pone.0163020","article-title":"Pharmacokinetics, safety and cognitive function profile of rupatadine 10, 20 and 40 mg in healthy Japanese subjects: a randomised placebo-controlled trial","volume":"11","author":"T\u00e4ubel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2018.08.011_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40629-014-0011-7","article-title":"Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects","volume":"23","author":"Shamizadeh","year":"2014","journal-title":"Allergo J Int"},{"key":"10.1016\/j.alit.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mai.2001.114239","article-title":"Desloratadine: a new, nonsedating, oral antihistamine","volume":"107","author":"Geha","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/14740338.2016.1221399","article-title":"Rupatadine: global safety evaluation in allergic rhinitis and urticaria","volume":"15","author":"Gonz\u00e1lez-N\u00fa\u00f1ez","year":"2016","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.alit.2018.08.011_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2018.08.011_bib16","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) MedDRA\u00ae the Medical Dictionary for Regulatory Activities. A registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); Chantilly, VA: Northrop Grumman MSSO (distributors). Available at: http:\/\/www.meddra.org\/. [Accessed 18 October 2018]."},{"key":"10.1016\/j.alit.2018.08.011_bib17","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_40. [Accessed 18 October 2018]."},{"issue":"Suppl 86","key":"10.1016\/j.alit.2018.08.011_bib18","first-page":"8","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"ousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2018.08.011_bib19","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.alit.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2222.2007.02888.x","article-title":"BSACI guidelines for the management of allergic and non-allergic rhinitis","volume":"38","author":"Scadding","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2018.08.011_bib21","unstructured":"European Medicines Agency. Guideline on the Clinical Development of Medicinal Products for the Treatment of Allergic Rhino-Conjunctivitis. EMEA\/CHMP\/EWP\/2455\/02. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003554.pdf. [Accessed 18 October 2018]."},{"key":"10.1016\/j.alit.2018.08.011_bib22","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research. Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry, February 2016. Available at: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm071293.pdf. [Accessed 18 October 2018]."},{"key":"10.1016\/j.alit.2018.08.011_bib23","first-page":"85","article-title":"Antihistamine onset of action: the importance to the patient","volume":"25","author":"Dolen","year":"2004","journal-title":"Allergy Asthma Proc"},{"issue":"1 Suppl","key":"10.1016\/j.alit.2018.08.011_bib24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1067\/mai.2001.115566","article-title":"Quality of life in adults and children with allergic rhinitis","volume":"108","author":"Meltzer","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.alit.2018.08.011_bib25","first-page":"1","article-title":"[Allergic Rhinitis QOL Questionnaire: its development and clinical usage]","volume":"52","author":"Okuda","year":"2003","journal-title":"Arerugi [Jpn J Allergol]"},{"issue":"2 Pt 1","key":"10.1016\/j.alit.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2018.08.011_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/00016480510026944","article-title":"Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires","volume":"125","author":"Okuda","year":"2005","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.alit.2018.08.011_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.alit.2016.05.014","article-title":"Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study","volume":"66","author":"Okubo","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2018.08.011_bib29","first-page":"863","article-title":"[A\u00a0Phase III clinical trial of desloratadine in Japanese subjects with seasonal allergic rhinitis -A randomized controlled trial-]","volume":"32","author":"Okubo","year":"2016","journal-title":"Rinshyo-iyaku"},{"key":"10.1016\/j.alit.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1517\/14656566.7.14.1989","article-title":"Rupatadine: pharmacological profile and its use in the treatment of allergic disorders","volume":"7","author":"Picado","year":"2006","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.alit.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2332\/allergolint.12-OA-0498","article-title":"Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline","volume":"62","author":"Gotoh","year":"2013","journal-title":"Allergol Int"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893018301199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893018301199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:09:13Z","timestamp":1761156553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893018301199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1323893018301199"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2018.08.011","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}